ExoPolymer is a biotechnology company applying modern strain engineering, synthetic biology, and fermentation to produce a completely novel and highly upgraded portfolio of biopolymer products. The firm is structured around production of an entirely new and substantially upgraded portfolio of biopolymer ingredients, or hydrocolloids, for the food, healthcare, personal care, and energy markets. Exopolymers patent-pending technology involves the development of a robust, safe, and economical biological platform for the production of proprietary target molecules that are substantially improved over currently available products. It has been decades since many of today's in-use polymers with - since then - minimal upgrade: performance limitations and variability. Today's Consumer is more concerned re. ingredients in food, healthcare, and personal care products - a concern that leads ExoPolymer to address the design and manufacture of next-generation, custom biopolymers providing superior value and consistency across all forms of exopolymer usage.